Literature DB >> 12970633

Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.

Kazuo Itabashi1, Tsutomu Ohno, Hiroshi Nishida.   

Abstract

OBJECTIVES: We evaluated the factors related to indomethacin responsiveness of the patent ductus arteriosus (PDA) and subsequent renal and electrolyte abnormalities in a large number of low birth weight infants.
METHODS: The ductus was evaluated by Doppler echocardiogram or clinical signs after the last administration of indomethacin for 2538 low birth weight infants, through the use of postmarketing surveillance data.
RESULTS: Multivariate logistic regression analyses demonstrated that clinical closure of PDA was significantly associated with pregnancy-induced hypertension and respiratory distress syndrome. In contrast, a 1-point increase of cardiovascular dysfunction score or a 1-day increase in postnatal age at the first indomethacin treatment decreased the responsiveness of the ductus to indomethacin. Clinical ductal reopening was significantly less likely to occur for each week of increased gestational age. Ductal reopening was more likely for each day of postnatal life at the first administration of indomethacin. Infants with preexisting renal and electrolyte abnormalities and infants whose mothers had received indomethacin tocolysis or who had chorioamnionitis were at increased risk of development of renal impairment.
CONCLUSIONS: Both antenatal and postnatal factors predict good or poor response to indomethacin therapy for PDA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970633     DOI: 10.1067/S0022-3476(03)00303-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  20 in total

1.  Predictors of successful closure of patent ductus arteriosus with indomethacin.

Authors:  M F Ahamed; P Verma; S Lee; M Vega; D Wang; M Kim; M Fuloria
Journal:  J Perinatol       Date:  2015-04-09       Impact factor: 2.521

2.  CYP2C9*2 is associated with indomethacin treatment failure for patent ductus arteriosus.

Authors:  Sydney R Rooney; Elaine L Shelton; Ida Aka; Christian M Shaffer; Ronald I Clyman; John M Dagle; Kelli Ryckman; Tamorah R Lewis; Jeff Reese; Sara L Van Driest; Prince J Kannankeril
Journal:  Pharmacogenomics       Date:  2019-08       Impact factor: 2.533

3.  Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.

Authors:  Nansi S Boghossian; Barbara T Do; Edward F Bell; John M Dagle; Jane E Brumbaugh; Barbara J Stoll; Betty R Vohr; Abhik Das; Seetha Shankaran; Pablo J Sanchez; Myra H Wyckoff; M Bethany Ball
Journal:  Early Hum Dev       Date:  2017-07-08       Impact factor: 2.079

4.  Risk factors associated with acute kidney injury in extremely low birth weight (ELBW) infants.

Authors:  Sreekanth Viswanathan; Bindu Manyam; Timur Azhibekov; Maroun J Mhanna
Journal:  Pediatr Nephrol       Date:  2011-08-03       Impact factor: 3.714

Review 5.  Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal period.

Authors:  Jeff Reese; Alex Veldman; Lisa Shah; Megan Vucovich; Robert B Cotton
Journal:  Semin Perinatol       Date:  2010-06       Impact factor: 3.300

6.  Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.

Authors:  Juliette C Madan; Douglas Kendrick; James I Hagadorn; Ivan D Frantz
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

7.  Patent ductus arteriosus is associated with acute kidney injury in the preterm infant.

Authors:  Batoule Majed; David A Bateman; Natalie Uy; Fangming Lin
Journal:  Pediatr Nephrol       Date:  2019-01-31       Impact factor: 3.714

8.  Indomethacin use for the management of patent ductus arteriosus in preterms: a web-based survey of practice attitudes among neonatal fellowship program directors in the United States.

Authors:  S B Amin; C Handley; O Carter-Pokras
Journal:  Pediatr Cardiol       Date:  2007-04-24       Impact factor: 1.655

9.  Multiple courses of indomethacin and neonatal outcomes in premature infants.

Authors:  Madhavi Sangem; Sumita Asthana; Sanjiv Amin
Journal:  Pediatr Cardiol       Date:  2007-12-18       Impact factor: 1.655

10.  Risk factors and mortality rate in premature babies with acute kidney injury.

Authors:  Ahmet Taner Elmas; Yılmaz Tabel; Ramazan Özdemir
Journal:  J Clin Lab Anal       Date:  2018-03-31       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.